1,2-dimethylhydrazine decreases expression ISO RGD:1314460 6480464 1, 2-Dimethylhydrazine results in decreased expression of PGM2 mRNA CTD PMID:22206623 17beta-estradiol multiple interactions ISO RGD:1314459 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of PGM2 mRNA CTD PMID:30165855 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO RGD:1314459 6480464 Metribolone results in increased expression of PGM2 protein CTD PMID:17152098 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1314459 6480464 Dihydrotestosterone results in increased expression of PGM2 mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1314459 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1314459 6480464 Tetrachlorodibenzodioxin results in decreased expression of PGM2 mRNA CTD PMID:17101203 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PGM2 mRNA CTD PMID:26232522 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1314460 6480464 Tetrachlorodibenzodioxin affects the expression of PGM2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1314460 6480464 Tetrachlorodibenzodioxin results in decreased expression of PGM2 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1314460 6480464 [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of PGM2 gene CTD PMID:21212295 2,3,7,8-tetrachlorodibenzodioxine decreases methylation ISO RGD:1314460 6480464 Tetrachlorodibenzodioxin results in decreased methylation of PGM2 gene CTD PMID:21212295 2,4,6-tribromophenol increases expression ISO RGD:1314459 6480464 2 more ... CTD PMID:31675489 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1314459 6480464 tetrabromobisphenol A results in increased expression of PGM2 protein CTD PMID:31675489 acetamide increases expression EXP 6480464 acetamide results in increased expression of PGM2 mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:1314459 6480464 Acrylamide results in decreased expression of PGM2 mRNA CTD PMID:32763439 aflatoxin B1 decreases expression ISO RGD:1314459 6480464 Aflatoxin B1 results in decreased expression of PGM2 mRNA CTD PMID:27153756 antirheumatic drug decreases expression ISO RGD:1314459 6480464 Antirheumatic Agents results in decreased expression of PGM2 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1314459 6480464 aristolochic acid I results in decreased expression of PGM2 mRNA CTD PMID:33212167 arsenous acid decreases expression ISO RGD:1314460 6480464 Arsenic Trioxide results in decreased expression of PGM2 mRNA CTD PMID:29095437 arsenous acid increases expression ISO RGD:1314459 6480464 Arsenic Trioxide results in increased expression of PGM2 protein CTD PMID:25419056 arsenous acid multiple interactions ISO RGD:1314460 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of PGM2 mRNA] CTD PMID:29095437 atrazine decreases expression ISO RGD:1314459 6480464 Atrazine results in decreased expression of PGM2 mRNA CTD PMID:22378314 benzo[a]pyrene increases mutagenesis ISO RGD:1314459 6480464 Benzo(a)pyrene results in increased mutagenesis of PGM2 gene CTD PMID:25435355 benzo[a]pyrene increases methylation ISO RGD:1314459 6480464 Benzo(a)pyrene results in increased methylation of PGM2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1314460 6480464 Benzo(a)pyrene results in increased expression of PGM2 mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1314459 6480464 7 more ... CTD PMID:26238291 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PGM2 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1314460 6480464 bisphenol A results in decreased expression of PGM2 protein CTD PMID:35999755 bisphenol A decreases methylation ISO RGD:1314459 6480464 bisphenol A results in decreased methylation of PGM2 gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:1314459 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PGM2 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:1314459 6480464 bisphenol A results in decreased expression of PGM2 protein CTD PMID:31675489 , PMID:34186270 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PGM2 mRNA CTD PMID:34947998 Bisphenol B increases expression ISO RGD:1314459 6480464 bisphenol B results in increased expression of PGM2 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1314459 6480464 bisphenol F results in increased expression of PGM2 protein CTD PMID:34186270 caffeine increases phosphorylation ISO RGD:1314459 6480464 Caffeine results in increased phosphorylation of PGM2 protein CTD PMID:35688186 captan increases expression ISO RGD:1314460 6480464 Captan results in increased expression of PGM2 mRNA CTD PMID:31558096 carbon nanotube increases expression ISO RGD:1314460 6480464 Nanotubes, Carbon results in increased expression of PGM2 mRNA CTD PMID:25554681 carmustine affects response to substance ISO RGD:1314459 6480464 PGM2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 CGP 52608 multiple interactions ISO RGD:1314459 6480464 CGP 52608 promotes the reaction [RORA protein binds to PGM2 gene] CTD PMID:28238834 clofibrate multiple interactions ISO RGD:1314460 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PGM2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PGM2 mRNA] CTD PMID:17585979 cobalt dichloride decreases expression ISO RGD:1314459 6480464 cobaltous chloride results in decreased expression of PGM2 mRNA CTD PMID:19320972 cyclosporin A decreases expression ISO RGD:1314459 6480464 Cyclosporine results in decreased expression of PGM2 mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:1314459 6480464 Cyclosporine results in increased expression of PGM2 mRNA CTD PMID:25562108 decabromodiphenyl ether increases expression ISO RGD:1314459 6480464 decabromobiphenyl ether results in increased expression of PGM2 protein CTD PMID:31675489 dextran sulfate decreases expression ISO RGD:1314460 6480464 Dextran Sulfate results in decreased expression of PGM2 protein CTD PMID:35999755 diarsenic trioxide multiple interactions ISO RGD:1314460 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of PGM2 mRNA] CTD PMID:29095437 diarsenic trioxide increases expression ISO RGD:1314459 6480464 Arsenic Trioxide results in increased expression of PGM2 protein CTD PMID:25419056 diarsenic trioxide decreases expression ISO RGD:1314460 6480464 Arsenic Trioxide results in decreased expression of PGM2 mRNA CTD PMID:29095437 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of PGM2 mRNA CTD PMID:21266533 dicrotophos decreases expression ISO RGD:1314459 6480464 dicrotophos results in decreased expression of PGM2 mRNA CTD PMID:28302478 disodium selenite increases expression ISO RGD:1314459 6480464 Sodium Selenite results in increased expression of PGM2 mRNA CTD PMID:18175754 diuron decreases expression EXP 6480464 Diuron results in decreased expression of PGM2 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1314459 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PGM2 mRNA CTD PMID:27188386 ethanol affects splicing ISO RGD:1314460 6480464 Ethanol affects the splicing of PGM2 mRNA CTD PMID:30319688 fipronil increases expression EXP 6480464 fipronil results in increased expression of PGM2 mRNA CTD PMID:23962444 fluoranthene multiple interactions ISO RGD:1314460 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PGM2 mRNA CTD PMID:28329830 folpet increases expression ISO RGD:1314460 6480464 folpet results in increased expression of PGM2 mRNA CTD PMID:31558096 fulvestrant multiple interactions ISO RGD:1314459 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PGM2 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of PGM2 mRNA CTD PMID:27387713 hydrogen peroxide increases expression ISO RGD:1314459 6480464 Hydrogen Peroxide results in increased expression of PGM2 mRNA CTD PMID:18951874 hydroquinone O-beta-D-glucopyranoside increases expression ISO RGD:1314459 6480464 Arbutin results in increased expression of PGM2 mRNA CTD PMID:17103032 ivermectin decreases expression ISO RGD:1314459 6480464 Ivermectin results in decreased expression of PGM2 protein CTD PMID:32959892 kojic acid increases expression ISO RGD:1314459 6480464 kojic acid results in increased expression of PGM2 mRNA CTD PMID:16595896 lipopolysaccharide decreases methylation ISO RGD:1314460 6480464 Lipopolysaccharides results in decreased methylation of PGM2 gene CTD PMID:21212295 lipopolysaccharide multiple interactions ISO RGD:1314460 6480464 [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of PGM2 gene CTD PMID:21212295 metformin multiple interactions ISO RGD:1314460 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of PGM2 mRNA] CTD PMID:29095437 nickel atom decreases expression ISO RGD:1314459 6480464 Nickel results in decreased expression of PGM2 mRNA CTD PMID:23195993 nickel atom increases expression ISO RGD:1314459 6480464 Nickel results in increased expression of PGM2 mRNA CTD PMID:25583101 paracetamol multiple interactions ISO RGD:1314460 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PGM2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PGM2 mRNA] CTD PMID:17585979 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PGM2 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1314459 6480464 Acetaminophen results in increased expression of PGM2 mRNA CTD PMID:21420995 perfluorooctane-1-sulfonic acid affects expression ISO RGD:1314460 6480464 perfluorooctane sulfonic acid affects the expression of PGM2 mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1314460 6480464 perfluorooctane sulfonic acid results in decreased expression of PGM2 protein CTD PMID:26178269 perfluorooctanoic acid affects expression ISO RGD:1314460 6480464 perfluorooctanoic acid affects the expression of PGM2 mRNA CTD PMID:19429403 perfluorooctanoic acid multiple interactions ISO RGD:1314460 6480464 Dietary Fats, Unsaturated inhibits the reaction [perfluorooctanoic acid results in increased expression of PGM2 mRNA] CTD PMID:23626681 phenylmercury acetate increases expression ISO RGD:1314459 6480464 Phenylmercuric Acetate results in increased expression of PGM2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1314459 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PGM2 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1314459 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PGM2 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:1314460 6480464 pirinixic acid results in increased expression of PGM2 mRNA CTD PMID:17426115 , PMID:18301758 quercetin decreases expression ISO RGD:1314459 6480464 Quercetin results in decreased expression of PGM2 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:1314459 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of PGM2 mRNA CTD PMID:23557933 SB 431542 multiple interactions ISO RGD:1314459 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PGM2 mRNA CTD PMID:27188386 sunitinib decreases expression ISO RGD:1314459 6480464 Sunitinib results in decreased expression of PGM2 mRNA CTD PMID:31533062 temozolomide affects response to substance ISO RGD:1314459 6480464 PGM2 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 temozolomide increases expression ISO RGD:1314459 6480464 Temozolomide results in increased expression of PGM2 mRNA CTD PMID:31758290 tert-butyl hydroperoxide increases expression ISO RGD:1314460 6480464 tert-Butylhydroperoxide results in increased expression of PGM2 mRNA CTD PMID:15003993 tetrachloromethane increases expression ISO RGD:1314460 6480464 Carbon Tetrachloride results in increased expression of PGM2 mRNA CTD PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PGM2 mRNA CTD PMID:34492290 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of PGM2 mRNA CTD PMID:33387578 valproic acid affects expression ISO RGD:1314459 6480464 Valproic Acid affects the expression of PGM2 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1314459 6480464 Valproic Acid results in increased expression of PGM2 mRNA CTD PMID:23179753 more ...